ArticleScientific reports2026
Does mRNA-based COVID-19 vaccination in the subacute phase lead to microstructural brain changes? A prospective pilot MRI study using T1 relaxometry.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Messenger ribonucleic acid (mRNA)-based vaccines delivered via lipid nanoparticles (LNP) were pivotal in managing the severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic. While mild systemic reactions are common after vaccination, rare neurological complications have raised concerns about potential structural cerebral changes. This prospective pilot study tested the hypothesis that LNP-mRNA-based SARS-CoV-2 vaccination does not induce significant microstructural cerebral changes in healthy adults. Dedicated 3 Tesla brain MRI was performed at three time points: up to one month before the first vaccination (t1), and 1-2 weeks (t2) and 2-3 months (t3) after the second dose of either BNT162b2 or mRNA-1273. Across 85 MRI scans from 29 initially SARS-CoV-2-seronegative adults, 2D T2-weighted fluid-attenuated inversion recovery, synthetic 3D T1 magnetization prepared rapid acquisition of gradient echoes and 3D quantitative T1 mapping were analyzed. Changes in w matter hyperintensities (WMH) were evaluated visually (Prins scale) and semiquantitatively (Longitudinal Brain Imaging). Microstructural changes of deep and cortical gray matter and white matter were analyzed using qT1 values via paired t-tests or Wilcoxon signed-rank tests. No new or progressive WMH nor significant intraindividual qT1 changes were observed. QT1% deviations were small (mean 0.1%, SD 0.9%; maximum 2.08%) and remained within established scan-rescan variability limits at 3 T. Apart from a 1 mm decrease of a preexisting WMH in one participant, no visually detectable structural brain alterations were observed. Our findings provide no evidence for WMH progression or microstructural cerebral changes after LNP-mRNA-based SARS-CoV-2 vaccination in healthy adults in the subacute phase.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.